Form 4: UHS Director Nimetz Reports Stock Transaction

Warren J. Nimetz, a Director at Universal Health Services Inc., reported a transaction involving Class B Common Stock on May 20, 2026.

Summary

• Warren J. Nimetz, a Director at Universal Health Services Inc. (UHS), reported a transaction on May 20, 2026.
• The transaction involved the acquisition of 1,217 shares of Class B Common Stock.
• Following this transaction, Mr. Nimetz beneficially owns 9,698 shares of Class B Common Stock.
• The acquisition was made under a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c) affirmative defense conditions.
• The reported securities were granted under the Universal Health Services, Inc. Amended and Restated 2020 Omnibus Stock and Incentive Plan.
• These restricted stock units are set to vest on the earlier of May 20, 2027, or the next annual meeting of stockholders occurring at least 50 weeks after the May 20, 2026 annual meeting.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it represents a routine disclosure of a director's stock transaction under a pre-arranged plan, with no immediate indication of significant positive or negative company performance.

Positives

• Director Warren J. Nimetz acquired 1,217 shares of Class B Common Stock, increasing his beneficial ownership.
• The transaction was made under a Rule 10b5-1(c) plan, indicating pre-planned and potentially defensive trading activity.
• The restricted stock units are part of an incentive plan, suggesting alignment with long-term company performance.

Future Outlook

Restricted stock units granted under the incentive plan are scheduled to vest on May 20, 2027, or the next annual meeting of stockholders, whichever comes first, provided the meeting is at least 50 weeks after the May 20, 2026 annual meeting.

Industry Context

StockSavvy.ai notes that Form 4 filings, like this one from Universal Health Services Inc., are standard disclosures for insider transactions. These filings provide transparency into the trading activities of company directors and officers, which can be a signal to the market, though often these are part of pre-arranged trading plans.

Stakeholder Impact

• Shareholders: Increased transparency into director's holdings and transactions. The acquisition under a 10b5-1 plan suggests a pre-determined trading strategy rather than a reaction to new information.

Next Steps

• Vesting of restricted stock units on May 20, 2027, or the subsequent annual meeting date.

Key Dates

Keywords

Universal Health Services, UHS, Form 4, Insider Trading, Stock Transaction, Director, Class B Common Stock, Restricted Stock Units, 10b5-1 Plan, Beneficial Ownership